Renaissance Technologies’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $41K | Sell |
|
|||||
|
2023
Q2 | $426K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $19K | Sell |
|
|||||
|
2022
Q3 | $246K | Buy |
|
|||||
|
2022
Q2 | $47K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $181K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $124K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $1.58M | Sell |
|
|||||
|
2020
Q1 | $2.68M | Buy |
|
|||||
|
2019
Q4 | $1.43M | Buy |
|
|||||
|
2019
Q3 | $1.16M | Buy |
|
|||||
|
2019
Q2 | $886K | Buy |
|
|||||
|
2019
Q1 | $880K | Buy |
|
|||||
|
2018
Q4 | $648K | Buy |
|
|||||
|
2018
Q3 | $511K | Buy |
|
|||||
|
2018
Q2 | $450K | Buy |
|
|||||
|
2018
Q1 | $281K | Sell |
|
|||||
|
2017
Q4 | $449K | Buy |
|
|||||
|
2017
Q3 | $95K | Buy |
|